Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v5-FR Version v1-EN
Language French English
Date Updated 2023-07-11 2023-06-08
Drug Identification Number 02464284 02464284
Brand name ADLYXINE ADLYXINE
Common or Proper name ADLYXINE ADLYXINE
Company Name SANOFI-AVENTIS CANADA INC SANOFI-AVENTIS CANADA INC
Ingredients LIXISENATIDE LIXISENATIDE
Strength(s) 20MCG 20MCG
Dosage form(s) SOLUTION SOLUTION
Route of administration SUBCUTANEOUS SUBCUTANEOUS SUBCUTANEOUS SUBCUTANEOUS
Packaging size 2 2
ATC code A10BJ A10BJ
ATC description
Reason for discontinuation Business reasons Business reasons
Anticipated discontinuation date 2023-09-05 2023-12-04
Actual discontinuation date
Remaining supply date
Discontinuation status To be discontinued To be discontinued
Discontinuation decision reversal no no
Tier 3 Status No No
Information on remaining supply
Company comments
Health Canada comments